Acquisition, etc

EVC Christows PLC 2 March 2001 EVC CHRISTOWS PLC Acquisition, variation of rights attaching to Warrants and Further Subscription Rights, proposed change of name, 1 for 10 Ordinary Share and 2.5p Warrant consolidation and agreement with Oliver Vaughan Highlights * Conditional acquisition of Evolution Capital Limited * Strengthening of the Board with key Evolution directors * Accelerated discounted exercise of all remaining Warrants and Further Subscription Rights * 1 for 10 Ordinary Share and 2.5p Warrant consolidation * Change of name to The Evolution Group Plc * EGM and meeting of 2.5p Warrantholders convened for 26 March 2001 Commenting on today's developments Alex Snow, group Chief Executive stated: 'The proposals we are now putting forward are of vital significance to the group as it moves forward with its stated strategy. The team at Evolution brings a high level of intellectual capital, corporate implementation and disciplined research expertise to our private and public equity group. Evolution's key sectors of interest and expertise include nanotechnology, wireless telecommunications, emerging engineering technology and other enabling technologies. The acceleration of the exercise date of the warrants and further subscription rights to 6 April 2001 is clearly critical to complete this vital acquisition and to allow the group to implement its key objectives. We have experienced extraordinary capital markets in the last 12 months. During that time we acquired Christows, a growing retail stockbroker and wealth management business and now through the acquisition of Evolution we are acquiring a disciplined and credible team that provides significant value to our portfolio and strategic expertise in the key areas of enabling and destructive technologies that we believe will generate significant growth over the next five years for the group. Evolution Capital has already initiated and in-depth and far reaching analysis of the private equity portfolio that was eVestment, and is at an advanced stage in reporting its findings back to the Board. Clearly the research discipline of Evolution Capital is a vital turning point in focussing our investment horizon and critical for the new strategy.' Further enquiries: Alex Snow - Chief executive 020 7444 1730 Adrian Graham - Finance Director 020 7937 4445 Definitions set out in the Company's circular dated 2 March 2001 apply throughout the following announcement. Copies of the circular are being posted to Shareholders today and will be available for a period of one month from today's date from the Company's registered office at 223A Kensington High Street, London, W8 6SG. 1. Background to the Proposals Further to the announcement made on 8 February 2001, the Company announces that it has conditionally acquired 99.4 per cent. of the issued share capital of Evolution Capital Limited. The remaining 0.6 per cent. of Evolution is held by Oliver Vaughan, and is expected to be dealt with separately as described below. The consideration for the Acquisition is the issue to the Vendors of up to a total of 21,739,130 New Ordinary Shares (of which 4,287,373 New Ordinary Shares will be reserved for issue in connection with the rollover of options held in Evolution, as described below) valuing Evolution at a total of £12.5 million. Under the AIM Rules, this transaction does not of itself require the approval of Shareholders. However the Vendors have agreed to sell Evolution on condition that the terms of the 2.5p Warrants, the 1p Warrants (together the 'Warrants') and the Further Subscription Rights ('FSRs') are amended on the basis outlined below. Shareholders and 2.5p Warrantholders who received the circular dated 26 October 2000 in connection with the acquisition of Christows Group Limited may recall the Board's own concern about the continued existence of those rights and Oliver Vaughan undertook then to make further proposals to resolve the issue. In particular the Board has become concerned that the continued existence of the Warrants and the Further Subscription Rights is not only confusing to Shareholders and potential investors, but has also given rise to a material disincentive to creating and issuing options with which to attract and incentivise senior management. As the Company pursues its strategy to become a provider of principal investment, research, due diligence and advisory services, the need for such incentivisation becomes all the more pressing. It is the Board's strongly held view that without the full implementation of the Proposals now being put to Shareholders, the development of the Company in line with its chosen strategy will be seriously impaired. The proposed acquisition of Evolution, and the attitude of the Vendors to the continued existence of the Warrants and the Further Subscription Rights, both underlines the issue and gives us the opportunity to resolve it. It is now proposed to deal with the Warrants and FSRs by shortening the period in which the rights attaching to the Warrants and the FSRs can be exercised so that it ends on 6 April 2001, whilst reducing the exercise price by factors of 90 per cent. and approximately 78 per cent. respectively, the difference reflecting the earlier current final exercise date of the FSRs as compared to the Warrants. These changes will require the approval of Shareholders and 2.5p Warrantholders. Chris Roberts and Adrian Graham each hold 3.2 million 2.5p Warrants and Tom Vaughan (who has been a director within the last year) holds 12.4 million 2.5p Warrants. Accordingly, the making of and acceptance of the Proposals in relation to the 2.5p Warrants by the Company to such Directors and former director constitutes a related party transaction for the purposes of the AIM Rules. Chris Roberts and Adrian Graham have therefore taken no part in the deliberations of the Board relating to the Proposals or the Board's recommendation of the Proposals to Shareholders and 2.5p Warrantholders. Whilst the terms of this arrangement will, if approved, result in the Company foregoing approximately £2.78 million in cash which it would otherwise receive pursuant to a normal exercise of the Warrants and FSRs, in view of the Company's current cash surplus and the need to create suitable means of incentivisation for senior management, as referred to above, the Independent Directors are of the opinion that the benefits of the early removal of such Warrants and FSRs outweigh the cash foregone. The Board also considers that now is an opportune time to effect a consolidation of the Company's ordinary share capital, and to change the name of the Company to a name which incorporates the 'Evolution' brand. It is also now proposed that the 2.5p Warrants be consolidated on the same basis as the ordinary share capital, pending the lapse of the 2.5p Warrants (or the Adjusted 2.5p Warrants, following the date of the EGM and the 2.5p Warrantholders' Meeting), which is expected to take place on 6 April 2001. Section 320 of the Companies Act applies to the proposed purchase by the Company from Oliver Vaughan of his 0.6 per cent. interest in Evolution, and accordingly no agreement can be reached with Mr Vaughan without the prior approval of Shareholders. This will be sought at the EGM, and Mr Vaughan has agreed in principle that he will enter into an agreement to sell his shares in Evolution to the Company on the same terms as the Vendors. Accordingly Mr Vaughan has taken no part in the deliberations of the Board relating to the Proposals or the Board's recommendation of the Proposals to Shareholders and 2.5p Warrantholders. 2. Details on the Acquisition Evolution is an independent company which provides research, strategic advice and proprietary funding for private and public companies seeking to identify and develop new enabling technologies capable of global commercial exploitation. Evolution's key sectors of interest and expertise include nanotechnology, wireless telecommunications, emerging engineering technology and other enabling technologies. The Company has consistently stated its intention to become a leading provider of principal investment, research, due diligence and advisory services (to private and public companies). The acquisition of Evolution significantly achieves that aim and gives EVC Christows the platform from which to develop its activities into investment banking. Evolution was incorporated in February 2000 and has not yet produced any audited financial statements. The agreement for the acquisition of the shares in Evolution (other than those held by Mr Vaughan) is conditional on, inter alia, the approval by Shareholders of the resolution relating to the share consolidation and the amendments to the Warrants and FSR instruments required to effect their early exercise, and the approval by 2.5p Warrantholders of the resolution in relation to the amendments to the 2.5p Warrant Instrument. Subject to satisfaction of the various conditions, the Company will on completion of the Acquisition allot the vendors 17,344,573 New Ordinary Shares, credited as fully paid at a price of 57.5p (being the mid-market closing price of the Ordinary Shares on 7 February 2001 of 5.75p, as adjusted for the Share Consolidation) for the current issued share capital of Evolution. These shares represent 15.7 per cent. of the Company's issued share capital following the Acquisition, assuming full exercise of the Warrants and FSRs. At the present time there are outstanding options over 4,000 shares in Evolution (the 'Evolution Options') which will be rolled into new options in the Company under a new scheme, the EVC Christows Evolution Acquisition Scheme ('the Acquisition Scheme'). The effect of deferring the exercise of the options is to reduce the initial consideration to be paid for Evolution from £ 12.5 million (as stated in the original announcement of the Acquisition on 8 February 2001) to £10.03 million. Under the Acquisition Scheme, a total of 4,287,373 New Ordinary Shares have been reserved for issue to the holders of the Evolution Options under the rolled over options and the exercise price will be 1p per New Ordinary Share. No further options will be granted under the Acquisition Scheme. Assuming all the options granted under the Acquisition Scheme are duly exercised, the total number of New Ordinary Shares issued in connection with the issued and to be issued share capital of Evolution will be 21,739,130 (including those shares to be allotted to Mr Vaughan subject to Shareholders' approval) representing an aggregate price of £12.5 million based on a valuation of 57.5p per New Ordinary Share. These shares represent 19.6 per cent. of the Company's issued share capital following the Acquisition, assuming full exercise of the Warrants and FSRs. Richard Griffiths, James Chilcott (both of whom are Proposed Directors), together with one other significant shareholder of Evolution have agreed to be subject to a lock in provision for a period of two years from completion of the Acquisition in respect of a total of 8,038,827 New Ordinary Shares. All holders of the Evolution Options have agreed to be bound in the same terms in respect of any New Ordinary Shares acquired by them pursuant to the Acquisition Scheme. Application has been made for the New Ordinary Shares, including those shares to be allotted in respect of the initial consideration for the Acquisition, and the Adjusted 2.5p Warrants to be admitted to trading on AIM. Dealings in the New Ordinary Shares and the Adjusted 2.5p Warrants are expected to commence on 27 March 2001. 3. The Share Consolidation The Board believes that it is now appropriate to reduce the number of shares in issue for several reasons, notably the level of costs associated with maintaining such a large number of shares and in an effort to reflect the changing nature of the shareholder register, which the Board believes is taking on an increasingly institutional bias. The Board has also become concerned by the volatility of the Company's share price which is believed, inter alia, to be a function of being a 'penny share'. Such volatility obviously presents a distinct difficulty when seeking to offer the Company's shares as acquisition consideration. Taking into account the proposed variations of the various Warrant instruments and the FSRs, your Board is recommending a share consolidation on the following basis: For every 10 Ordinary Shares currently held, a Shareholder will receive 1 New Ordinary Share and 1 Deferred Share. The Deferred Shares will have no commercial value and no application will be made for them to be admitted to trading on AIM or any other exchange. No certificates for Deferred Shares will be issued and in due course it is intended to make an application to the Court for their cancellation. Any fractional entitlements to New Ordinary Shares arising on the Share Consolidation will be aggregated and will be sold in the market and the proceeds of such sale (less any expenses, including value added tax, thereon) retained for the benefit of the Company (unless any Shareholder's entitlement exceeds £3.00, in which case the proceeds will be remitted to the Shareholder concerned). The Share Consolidation will be carried out after close of business on 26 March 2001, the day of the EGM 4. The 2.5p Warrant Consolidation Subject to the passing of the relevant resolutions at the EGM and the 2.5p Warrantholders' Meeting the 2.5p Warrants will also be consolidated on the same basis as the New Ordinary Shares. Following the EGM each 2.5p Warrant will be consolidated on the basis of: For every 10 2.5p Warrants currently held, a 2.5p Warrantholder will receive 1 Adjusted 2.5p Warrant. Any fractional entitlements to Adjusted 2.5p Warrants will be ignored. The consolidation of the 2.5p Warrants will be carried out after close of business on the day of the EGM. 5. Details on the accelerated discounted exercise of Warrants and FSRs For the reasons given above, it is now proposed to accelerate the date on which the 2.5p Warrants, 1p Warrants and FSRs will expire to 6 April 2001. In consideration of this change, it is proposed to reduce the subscription price per ordinary share by a factor of 90 per cent. in the case of the Warrants and approximately 78 per cent. in the case of the FSRs as follows: For every 10 2.5p Warrants currently held (or for every Adjusted 2.5p Warrant held after the consolidation), the holder will be entitled to subscribe for 1 New Ordinary Share at 2.5p prior to 6 April 2001, failing which the entitlement will lapse For every 10 1p Warrants currently held, the holder will be entitled to subscribe for 1 New Ordinary Share at 1p, prior to 6 April 2001, failing which the entitlement will lapse For every 10 FSRs currently held, the holder will be entitled to subscribe for 1 New Ordinary Share at 17.16p and 4 New Ordinary Shares at 2.5p, by 6 April 2001, failing which the entitlement will lapse. All the holders of the 1p Warrants and the FSRs have agreed to these changes, and to exercise in full their rights on the amended terms, subject to the passing of the relevant resolution at the EGM and not to dispose of their New Ordinary Shares for a further year without the consent of the Board, such consent not to be unreasonably withheld or delayed. The variation of the 2.5p Warrant Instrument requires the approval of 2.5p Warrantholders by a majority of 75 per cent. Persons (including directors and those connected with them) holding 18.8 million 2.5p Warrants (being 45.8 per cent. of the 2.5p Warrants) have irrevocably undertaken to vote in favour of the 2.5p Warrantholders' Resolution, and, subject to the passing of the relevant resolutions by Shareholders and 2.5p Warrantholders, to exercise in full their 2.5p Warrants on the amended terms and not to dispose of their New Ordinary Shares for a further year without the consent of the Board, such consent not to be unreasonably withheld or delayed. Holders of 2.5p Warrants (or Adjusted 2.5p Warrants following the date of the EGM and the 2.5p Warrantholders' Meeting) should appreciate that if the Proposals become effective their rights will lapse on 6 April 2001 if not previously exercised. Until that date the 2.5p Warrants (or Adjusted 2.5p Warrants following the date of the EGM and the 2.5p Warrantholders' Meeting) will continue to be traded on AIM. However, as soon as practicable after that date the Company will apply to the London Stock Exchange for cancellation of trading in the Adjusted 2.5p Warrants. 6. Change of name The Board considers the acquisition of Evolution to be a significant milestone in the development of the Company and therefore that the name of the Company should be changed to incorporate the 'Evolution' brand. Accordingly a special resolution to change the name of the Company to The Evolution Group Plc will be proposed at the EGM. The 'Christows' name will remain the name for the Company's core branded retail stockbroking and fund management business, enabling it to retain and build its distinct and separate status under the 'Christows' banner. Changing the Company's name to The Evolution Group Plc is intended to allow the rest of the business to develop under the 'Evolution' brand, which will continue to develop Evolution's own research and corporate finance activities as well as its principal investment capabilities. 7. Agreement with Mr Vaughan Oliver Vaughan, the Company's Chairman holds approximately 0.6 per cent. of the issued share capital of Evolution. Although he has agreed in principle to sell these shares to the Company on the same terms as the rest of the Vendors, such a sale requires the prior approval of the Shareholders under Section 320 of the Companies Act, which will be sought at the EGM. The principal term of the proposed arrangement with Mr Vaughan is that he will sell, and the Company will purchase, his shares in Evolution in consideration for the issue of 107,184 New Ordinary Shares. It is intended that the contract with Mr Vaughan, subject to its approval by Shareholders, will be signed once the agreement for the Acquisition is unconditional save as to admission of the New Ordinary Shares to AIM, with both agreements being completed simultaneously. 8. Board changes Further to the recent announcements concerning the composition of the Board, conditional on the Acquisition becoming unconditional in all respects, Richard Griffiths, James Kenny and James Chilcott of Evolution will join the Board. At the same time Chris Roberts and Jackie Donnelly will resign from the Board and leave the Company. The Board would like to take this opportunity to thank both of them for the very considerable contribution they have made to the Company. Richard Griffiths is the Chairman and a founding shareholder of Evolution. Mr Griffiths has extensive experience of company management, equity sales and trading and has also been an active investor in small and emerging companies, particularly in the hi-tech sector. Mr Griffiths has been a director of a number of private and publicly owned companies including Osmetech Plc where he was primarily responsible for its refinancing. Mr Griffiths previously acted as a director of the Dragon Special Situations Corporation and as joint investment manager of The Marlborough UK Equity Growth Fund. James Kenny is the Chief Executive Officer and a founding shareholder of Evolution. Mr Kenny has over 15 years' experience advising entrepreneurs and private and public companies on all aspects of corporate development and the equity capital markets. Mr Kenny has previously worked with Natwest Plc, Smurfit Group Plc, ABN AMRO Corporate Finance and most recently was a director of ABN AMRO Rothschild, the equity capital markets joint venture of NM Rothschild & Sons Limited and ABN AMRO Bank NV. While at ABN AMRO Rothschild, Mr Kenny had responsibility for all aspects of ABN AMRO Rothschild's primary equity capital markets activities in a number of European countries where he acted as a team leader on a number of major primary, secondary and privatisation offerings. Mr Kenny has a Bachelor of Commerce and a Master of Business Studies (Finance) from University College Dublin. James Chilcott is the Managing Director and a founding shareholder of Evolution; he also runs Evolution's Research Department. Most recently Mr Chilcott worked for Merrill Lynch Investment Managers (previously known as Mercury Asset Management) where he was a member of their internal strategy team. During his time with the team, he helped develop the organisation's on-line asset management strategy, and advised senior management on the deployment of new technologies. Mr Chilcott has also worked at Arthur D Little, a strategic technology consultancy, where he advised and implemented strategies for a number of blue chip clients. Mr Chilcott has a BSc. (Econ) from Cardiff University and an M. Phil from Cambridge University. On completion of the Acquisition it is intended that Mr Vaughan will step down as chairman to become a non-executive Director and Alexander Snow will become chairman as well as chief executive. The Board intends in due course to appoint a non-executive chairman at which point Alexander Snow will relinquish that role. Accordingly, following the Proposals the Board will comprise the following: Alexander Snow - Chairman and Group Chief Executive Richard Griffiths - Executive Deputy Chairman James Chilcott - Executive Director (Research) Adrian Graham - Finance Director James Kenny - Executive Director (Corporate Finance and Private Equity) Michael Read - Executive Director (Fund Management) John Gunn - Non executive Director Oliver Vaughan - Non executive Director Further details on the Proposed Directors and details of their proposed service contracts are set out below. 9. Recommendation The Independent Directors, who have been so advised by Peel Hunt, consider the Proposals to be in the best interests of the Company, its Shareholders and holders of Warrants. In providing its advice Peel Hunt has taken account of the Independent Directors' commercial assessment of the Proposals. Accordingly, the Independent Directors unanimously recommend Shareholders to vote in favour of the resolutions to be proposed at the EGM, as they intend to do in respect of their own shareholdings amounting in aggregate to 74,053,562 Ordinary Shares, representing approximately 9.6 per cent. of the issued ordinary share capital of the Company. The Independent Directors also unanimously recommend that the 2.5p Warrantholders vote in favour of the resolution to be proposed at the 2.5p Warrantholders' Meeting. The Directors have received irrevocable undertakings from Chris Roberts, Adrian Graham and Tom Vaughan, who together hold an aggregate of 18,800,000 2.5p Warrants (representing 45.8 per cent of the total number of outstanding 2.5p Warrants) to vote in favour of the 2.5p Warrantholders' Resolution. As explained above, the making of, and acceptance of the Proposals in relation to the 2.5p Warrants by the Company to Chris Roberts, Adrian Graham and Tom Vaughan constitutes a related party transaction for the purposes of the AIM Rules. The Independent Directors, having consulted with Peel Hunt, consider that the terms of such transaction are fair and reasonable insofar as Shareholders and 2.5p Warrantholders are concerned. 10. Further details of the Proposed Directors The Proposed Directors currently hold the following directorships and partnerships and have held the following directorships or partnerships within the five years prior to the publication of this announcement: Richard Ian Griffiths (aged 34) Current: Evolution Capital Limited, Nanomat Limited, Pinkeys Limited, First Beacon Investments Limited, Iron County Limited, EVO 1 Incorporated Past: Osmetech Plc, Dragon Special Situations Fund James Edward Chilcott (aged 30) Current: Asian Technology Investment Trust, Evolution Capital Limited, Evolution Capital Finance Limited Past: None James Kenny (aged 35) Current: Firestone Diamonds plc, Evolution Capital Limited, Evolution Capital Finance Limited, EVO 1 Incorporated Past: ABN AMRO Rothschild, ABN .AMRO Corporate Finance (Ireland) Limited No Proposed Director: (i) has any unspent convictions in relation to indictable offences; (ii) has become bankrupt or entered into any voluntary arrangements; (iii) has been a director of any company or partner of any firm which, at the time or within 12 months of ceasing to be a director or partner (as the case may be), had a receiver appointed or was liquidated or went into administration, or entered into company or partnership voluntary arrangements or made any composition or arrangement with its creditors; (iv) has had any public criticism against him by statutory or regulatory authority (including a recognised professional body) or has ever been disqualified by a Court from acting as a director of a company or from acting in the management or the conduct of the affairs of a company; or (v) has been involved in any receivership of any of his assets or of any assets of a partnership of which he was a partner at the time of or within 12 months preceding such events. 11. Service Contracts of the Proposed Directors On completion of the Acquisition each of the Proposed Directors will enter into a service contract with the Company, the principal terms of which, in each case, are as follows: (i) a salary of £140,000; (ii) participation in the Company's medical expenses and life insurance schemes; (iii) entitlement to an annual discretionary bonus; (iv)entitlement to a motor vehicle with an annual leasing cost not exceeding £10,000, or a cash equivalent; and (v) a notice period of one year at any time.

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings